All News Shield Therapeutics plc

Equities

Delayed London S.E. Other stock markets 04:52:07 2024-05-21 am EDT			5-day change	1st Jan Change
1.882 ^GBX	+7.54%		-5.90%	-71.91%

May. 10	Shield Therapeutics plc Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Apr. 30	EARNINGS AND TRADING: Software Circle & Beximco report higher revenue	AN

Shield Therapeutics : 2023 Annual Report and Accounts	May. 10	PU
Shield Therapeutics : Notice of Annual General Meeting 2024	May. 10	PU
Shield Therapeutics : Letter to Shareholders 2024	May. 10	PU
Shield Therapeutics plc Reports Earnings Results for the Full Year Ended December 31, 2023	May. 09	CI
EARNINGS AND TRADING: Software Circle & Beximco report higher revenue	Apr. 30	AN
Transcript : Shield Therapeutics plc, 2023 Earnings Call, Apr 30, 2024	Apr. 30
Transcript : Shield Therapeutics plc, 2023 Sales/ Trading Statement Call, Feb 22, 2024	Feb. 22
FTSE 100 takes hit ahead of FOMC minutes	Feb. 21	AN
Shield Therapeutics sinks as strong performance marred by data issues	Feb. 21	AN
Shield Therapeutics plc Announces Unaudited Sales Results for the Year Ended 31 December 2023	Feb. 21	CI
Shield Therapeutics hires former Akili leader as new CFO	Jan. 09	AN
Shield Therapeutics Names New CFO	Jan. 09	MT
Shield Therapeutics Appoints Santosh Shanbhag as New CFO, Effective January 16, 2024	Jan. 08	CI
Comptoir opens restaurant; Intercede wins contract	Dec. 07	AN
Hardman & Co Research on Shield Therapeutics (STX): Accelerating effectiveness of enlarged sales team	Nov. 15	EQ
Shield to Present Abstract at 26th Annual Women's Healthcare Conference 2023 on Accrufer	23-10-23	AQ
FTSE 100 Ends Higher Fueled by Energy Stocks	23-10-12	DJ
Shield Therapeutics Chief Financial Officer Rudolf to leave	23-10-12	AN
AIM WINNERS & LOSERS: Windward sees high contracting activity levels	23-10-12	AN
Shield Therapeutics CFO to Step Down	23-10-12	MT

No results for this search